Seems there is some differences of opinion on whether GSK's newly-launched Discovery Fast Track competition for academic institutions is a good thing or just a way to rip off university IP.
http://www.fiercebiotech.com/story/ucla-slams-door-glaxosmithklines-latest-rd-competition/2013-05-30#ixzz2UnUjQxPy
Any experience with this program so far? Should I apply?
↧